The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Not to mention that like, you know, beta-hydroxybutyrate has been identified to be signaling molecule as well. I think Eric Verdin's work at UCSF has showed it's a class one in histone deacetylase inhibitor, I mean, who knows what's going on.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
these epigenetic changes with beta-hydroxybutyrate being an epigenetic modulator, a signaling molecule, autophagy's one that I'm very interested in as well?